Skip to main content

Table 3 Type of treatment and prevalence parasitological diagnosis before treatment by source among individuals who reported having fever in last two weeks and who took action (N = 2,035).

From: Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan

 

Use of any drug, % (95% CI) (n/N = 1,935/2,035)

Use of anti-malarials, % (95% CI) (n/N = 875/2,025)

Use of other drugs, % (95% CI) (n/N = 1,060/2,035)

Parasitologically tested for malaria before any treatment, % (95% CI) (n = 1,015/2,035)*

Overall

95.4 (94.4-96.4)

42.6 (39.2-46.0)

57.4 (54.0-60.8)

52.8 (48.6-57.0)

By treatment source

Government

    

Hospital

29.0 (25.1-32.9)

28.2 (23.1-33.4)

29.6 (25.4-33.7)

38.8 (33.1-44.6)

Health centre

30.3 (26.4-34.3)

33.7 (28.2-39.2)

27.7 (23.7-31.7)

36.9 (31.4-42.4)

Basic health unit

11.4 (8.1-14.5)

11.4 (7.4-15.5)

11.3 (8.1-14.6)

4.6 (2.8-6.2)

Community Health Worker

6.9 (4.5-9.3)

5.9 (3.2-8.6)

7.7 (4.9-10.6)

3.4 (1.9-5.0)

Private

    

Health facility/pharmacy/drug Store

15.3 (12.8-17.7)

16.0 (12.3-19.7)

14.7 (12.0-17.5)

15.2 (11.6-18.9)

Shop

5.5 (4.0-6.9)

3.8 (2.2-5.3)

6.8 (4.8-8.8)

0.4 (0.0-0.9)

Other

1.6 (0.9-2.3)

9.5 (0.2-1.7)

2.2 (1.0-3.3)

0.5 (0.0-1.1)

  1. Proportions are weighted and cluster adjusted.
  2. *Individuals tested for malaria when reporting at a health facility with fever. 57% of these received anti-malarials compared to 29% of those who were not tested. It was not possible to discern whether only the positive cases were treated with anti-malarials because of problems with recall and incompleteness of test status.